Annals of Hepatology (Jul 2022)

Non-invasive methods for iron overload evaluation in dysmetabolic patients

  • Paula Pessin Fábrega Branisso,
  • Claudia Pinto Marques Souza de Oliveira,
  • Hilton Muniz Leão Filho,
  • Fabiana Roberto Lima,
  • Aritânia Sousa Santos,
  • Marcio Correa Mancini,
  • Maria Edna de Melo,
  • Flair José Carrilho,
  • Manoel de Souza Rocha,
  • Paul Clark,
  • Henrique José Pereira Branisso,
  • Cintia Cercato

Journal volume & issue
Vol. 27, no. 4
p. 100707

Abstract

Read online

Introduction: Although hyperferritinemia may reflect the inflammatory status of patients with non-alcoholic fatty liver disease (NAFLD), approximately 33% of hyperferritinemia cases reflect real hepatic iron overload. Aim: To evaluate a non-invasive method for assessing mild iron overload in patients with NAFLD using 3T magnetic resonance imaging (MRI) relaxometry, serum hepcidin, and the expression of ferritin subunits. Methods: This cross-sectional study assessed patients with biopsy-proven NAFLD. MRI relaxometry was performed using a 3T scanner in all patients, and the results were compared with iron content determined by liver biopsy. Ferritin, hepcidin, and ferritin subunits were assessed and classified according to ferritin levels and to siderosis identified by liver biopsy. Results: A total of 67 patients with NAFLD were included in the study. MRI revealed mild iron overload in all patients (sensitivity, 73.5%; specificity, 70%). For mild (grade 1) siderosis, the transverse relaxation rate (R2*) threshold was 58.9 s−1 and the mean value was 72.5 s−1 (SD, 33.9), while for grades 2/3 it was 88.2 s−1 (SD, 31.9) (p 30.2 ng/mL (sensitivity, 87%; specificity, 82%). Ferritin H and ferritin L subunits were expressed similarly in patients with NAFLD, regardless of siderosis. There were no significant differences in laboratory test results between the groups, including glucose parameters and liver function tests. Conclusions: MRI relaxometry and serum hepcidin accurately assessed mild iron overload in patients with dysmetabolic iron overload syndrome.

Keywords